GLN-POSACONAZOLE
Identification of Gln-Posaconazole
| No description |
Google image searchProduct monograph
Active ingredient
posaconazole, 100 MG
DIN: 02542021
Dosage form(s): TABLET (DELAYED-RELEASE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: GLENMARK PHARMACEUTICALS CANADA INC.
Date: 04-OCT-2023
ATC:
- J02 — ANTIMYCOTICS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J02A — ANTIMYCOTICS FOR SYSTEMIC USE (ATC, ATC/DDD)
- J02AC — Triazole derivatives (ATC, ATC/DDD)
- J02AC04 — POSACONAZOLE (ATC/DDD)
Reference brand drug: Posanol
